Kelly Mabry is a technical leader passionate about bringing meaningful technologies from lab to market. She has developed comprehensive product development plans with a strong product foundation, developed supply chain & manufacturing strategies, and shaped regulatory submissions. Currently, she is the CEO of Cellia Science and a VIC Executive in Residence (EIR). Previously she was the Director of Research and Development at Tangible Science, where she has led the development of contact lens-related products from inception through development and on to FDA clearance and commercialization. A chemical engineer by training, she has worked at the interface of engineering, materials science, biology, and medicine. Her PhD thesis in the lab of Kristi Anseth of the University of Colorado focused on designing biomimetic materials systems for in vitro study of heart valve cells.